Literature DB >> 8898422

Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study.

G Hoff1, J Sauar, M H Vatn, S Larsen, F Langmark, I E Moen, A Foerster, E Thiis-Evensen.   

Abstract

BACKGROUND: The efficacy of polypectomy in preventing colorectal cancer (CRC) has never been demonstrated in a controlled, prospective study. This must be done by randomization within a population with a high prevalence of colorectal polyps, and the feasibility and safety of endoscopic screening examination is a prerequisite for this type of study.
METHODS: The present study is a randomized, controlled study of the feasibility and safety of flexible sigmoidoscopic screening of a normal population sample of 799 men and women aged 50-59 years, findings at 2 and 6 years' colonoscopic follow-up, and the appearance of clinical colorectal cancer (CRC) after 10 years.
RESULTS: The attendance rate was high, and there were no complications. After 10 years 1 of 400 in the screening group had developed CRC (in the group of 76 (19%) not attending for screening examination). Four of 399 controls developed CRC.
CONCLUSIONS: Poor yield of polyps at follow-up, slow growth of in situ polyps, and no clinical CRC among screenees after 10 years provides support to infrequent or no colonoscopic follow-up after initial polypectomy in individuals with otherwise average risk of CRC.

Entities:  

Mesh:

Year:  1996        PMID: 8898422     DOI: 10.3109/00365529609003121

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Colorectal cancer risk information presented by a nonphysician assistant does not increase screening rates.

Authors:  Thad Wilkins; Ralph A Gillies; Pina Panchal; Mittal Patel; Peter Warren; Robert R Schade
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

2.  Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.

Authors:  Scott D Ramsey; Wylie Burke; Linda Pinsky; Lauren Clarke; Polly Newcomb; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

3.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; J Dik F Habbema; Ernst J Kuipers
Journal:  J Natl Cancer Inst       Date:  2009-09-24       Impact factor: 13.506

4.  Risk related surveillance following colorectal polypectomy.

Authors:  G Nusko; U Mansmann; Th Kirchner; E G Hahn
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; Rob Boer; Janneke Wilschut; J Dik F Habbema
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

6.  Risk of advanced metachronous colorectal adenoma during long-term follow-up.

Authors:  G Nusko; E G Hahn; U Mansmann
Journal:  Int J Colorectal Dis       Date:  2008-07-03       Impact factor: 2.571

7.  Increasing prevalence of advanced colonic polyps in young patients undergoing colonoscopy in a referral academic hospital in Hong Kong.

Authors:  Tze-Jui Lam; Benjamin C Y Wong; Chris J J Mulder; A Salvador Peña; Wai Mo Hui; Shiu Kum Lam; Annie On On Chan
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

8.  Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: A randomized trial.

Authors:  Espen Thiis-Evensen; Mette Kalager; Michael Bretthauer; Geir Hoff
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

Review 9.  Blood-based testing for colorectal cancer screening.

Authors:  Karen A Heichman
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 10.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Authors:  Øyvind Holme; Michael Bretthauer; Atle Fretheim; Jan Odgaard-Jensen; Geir Hoff
Journal:  Cochrane Database Syst Rev       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.